Product Information

TOBRAMYCIN-DEXAMETH OPHTH SUSP is a generic product labeled by Sandoz Inc., priced at $3.6789 per ML under NDC 61314064705. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Aug 18, 1988. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOBRAMYCIN-DEXAMETH OPHTH SUSP

Tobramycin and Dexamethasone
$3.6789per ML

Strength

1; 3 mg/mL; mg/mL

Manufacturer

Sandoz Inc.

NDC

61314064705

Classification

Generic

Dosage Form

SUSPENSION/ DROPS

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

DEXAMETHASONE; TOBRAMYCIN

Approval Type

Authorized Generic (NDA)

FDA Application

NDA050592

FDA Approved

8/18/1988

TE Code

AB

On Market Since

1/2/2009

Pharmacological Classes

Aminoglycoside Antibacterial
Aminoglycosides
Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 78.5%. The table below summarizes its recorded NADAC range and movement.

Current price$3.6789 per ML
All-time high$17.7355 (Apr 16, 2014)
All-time low$3.6789 (Nov 18, 2026)
52-week high$4.7783
52-week low$3.6789
Median price$14.0436
Average price$11.9413
Largest weekly change+49.3% (Nov 22, 2023)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-2.3%

1M

-8.3%

3M

-13.8%

6M

-19.4%

1Y

-14.5%

3Y

-31.9%

5Y

-78.0%

All

-78.5%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TOBRAMYCIN-DEXAMETH OPHTH SUSP?

The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN-DEXAMETH OPHTH SUSP, manufactured by Sandoz Inc., is $3.6789 per ML (NDC 61314064705), effective Nov 18, 2026.

How has the price of TOBRAMYCIN-DEXAMETH OPHTH SUSP changed over time?

Over the history we have for it, the NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has declined 78.5%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TOBRAMYCIN-DEXAMETH OPHTH SUSP?

Since Nov 28, 2013, the NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has ranged from a low of $3.6789 (Nov 18, 2026) to a high of $17.7355 (Apr 16, 2014), with a median of $14.0436 per ML.

Are there cheaper alternatives to TOBRAMYCIN-DEXAMETH OPHTH SUSP?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TOBRAMYCIN-DEXAMETH OPHTH SUSP in a comparable dosage form, but none are currently priced below it.

Who manufactures TOBRAMYCIN-DEXAMETH OPHTH SUSP?

TOBRAMYCIN-DEXAMETH OPHTH SUSP (NDC 61314064705) is labeled by Sandoz Inc., and CMS classifies it as a generic product.